Company
Headquarters: Singapore, Singapore
CEO: Mr. Kum Meng Yet
S$124.4 Million
SGD as of July 1, 2024
US$91.6 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
OUE Lippo Healthcare Limited, an investment holding company, acquires, develops, operates, and manages healthcare facilities, healthcare-related assets, and integrated mixed-use projects in Japan and the People's Republic of China. The company operates through Healthcare Operations, Healthcare Assets, Properties Under Development, and Investments segments. Its facilities include medical centers, day surgeries, hospitals, nursing homes, and retirement communities. The company owns and operates 12 nursing homes in Japan, as well as one hospital in China. It also rents investment properties and assets; and trades in pharmaceutical supplies, drugs, and medical equipment, as well as invests in real estate investment trust. The company was formerly known as International Healthway Corporation Limited and changed its name to OUE Lippo Healthcare Limited in October 2017. The company was founded in 2010 and is based in Singapore. OUE Lippo Healthcare Limited is a subsidiary of OUE Limited.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
OUE Lippo Healthcare Ltd has the following listings and related stock indices.
Stock: SGX: 5WA wb_incandescent